Similar analysis including IL-1β, Rantes/CCL5, MCP1, GMCSF, TNFα, and IL-6 showed similar results with elevated IL-6 increasing the probability of having a cancer diagnosis (p < 0.0046) (Table 3). This evidence concerns the gene CCL2 and cancer.